ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)
CAPS Rating:
The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.
Invest Different
The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Will be bought or be a one hit wonder.